{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:46:51Z","timestamp":1780368411228,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2240"],"award-info":[{"award-number":["FOR2240"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009983","name":"Center for Molecular Medicine Cologne, University of Cologne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bbrep.2020.100866","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T23:13:05Z","timestamp":1606345985000},"page":"100866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["IFN-\u03b2 signaling dampens microglia reactivity but does not prevent from light-induced retinal degeneration"],"prefix":"10.1016","volume":"24","author":[{"given":"Verena","family":"Behnke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Langmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2020.100866_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants,","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrep.2020.100866_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science (80)"},{"key":"10.1016\/j.bbrep.2020.100866_bib3","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nm1201-1356","article-title":"Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment","volume":"7","author":"Priller","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrep.2020.100866_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","article-title":"Retinal microglia: just bystander or target for therapy?","volume":"45","author":"Karlstetter","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.bbrep.2020.100866_bib5","series-title":"Adv. Exp. Med. Biol.","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-4614-3209-8_27","article-title":"Microglia in the aging retina","author":"Karlstetter","year":"2014"},{"key":"10.1016\/j.bbrep.2020.100866_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/glia.20468","article-title":"Microglia derived from aging mice exhibit an altered inflammatory profile","volume":"55","author":"Sierra","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.bbrep.2020.100866_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1474-9726.2010.00660.x","article-title":"Age-related alterations in the dynamic behavior of microglia","volume":"10","author":"Damani","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbrep.2020.100866_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0014-4835(02)00332-9","article-title":"Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration","volume":"76","author":"Gupta","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrep.2020.100866_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.15252\/emmm.201404524","article-title":"Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration","volume":"7","author":"Levy","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrep.2020.100866_bib10","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1172\/JCI31692","article-title":"CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration","volume":"117","author":"Combadi\u00e8re","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrep.2020.100866_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1189\/jlb.0207114","article-title":"Microglia activation in retinal degeneration","volume":"81","author":"Langmann","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrep.2020.100866_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fncel.2018.00176","article-title":"Microglia activation and immunomodulatory therapies for retinal degenerations","volume":"12","author":"Rashid","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbrep.2020.100866_bib13","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.R700004200","article-title":"The interferons: 50 Years after their discovery, there is much more to learn","volume":"282","author":"Pestka","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2020.100866_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.6-1-34","article-title":"Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities","volume":"6","author":"Jonasch","year":"2001","journal-title":"Oncol."},{"key":"10.1016\/j.bbrep.2020.100866_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cytogfr.2014.10.010","article-title":"IFN-\u03b2 and multiple sclerosis: from etiology to therapy and back","volume":"26","author":"Annibali","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbrep.2020.100866_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrep.2020.100866_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrep.2020.100866_bib18","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.R700006200","article-title":"Type I interferon receptors: biochemistry and biological functions","volume":"282","author":"De Weerd","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2020.100866_bib19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.immuni.2008.04.006","article-title":"Type 1 interferons cool the inflamed brain","volume":"28","author":"Axtell","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.bbrep.2020.100866_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.immuni.2008.03.011","article-title":"Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system","volume":"28","author":"Prinz","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.bbrep.2020.100866_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.15252\/emmm.201505994","article-title":"Interferon\u2010beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization","volume":"8","author":"L\u00fcckoff","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrep.2020.100866_bib22","first-page":"1","article-title":"Targeting translocator protein (18 kDa) (TSPO) dampens pro-inflammatory microglia reactivity in the retina and protects from degeneration","volume":"12","author":"Scholz","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbrep.2020.100866_bib23","first-page":"1","article-title":"Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration","volume":"12","author":"Scholz","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbrep.2020.100866_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/MMBR.00024-13","article-title":"Mx proteins: antiviral gatekeepers that restrain the uninvited","volume":"77","author":"Verhelst","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bbrep.2020.100866_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000336","article-title":"Type i interferons in host defence and inflammatory diseases","volume":"6","author":"Crow","year":"2019","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.bbrep.2020.100866_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis - the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrep.2020.100866_bib27","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.4049\/jimmunol.170.9.4776","article-title":"IFN-\u03b2 gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis","volume":"170","author":"Teige","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2020.100866_bib28","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.4049\/jimmunol.135.3.1857","article-title":"Antagonistic effect on interferon-\u03b2 on the interferon-\u03b3-induced expression of Ia antigen in murine macrophages","volume":"135","author":"Ling","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2020.100866_bib29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neuropharm.2003.11.007","article-title":"Effects of interferon-\u03b2 on microglial functions as inflammatory and antigen presenting cells in the central nervous system","volume":"46","author":"Kawanokuchi","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrep.2020.100866_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/08923979809034808","article-title":"Effect of propranolol and IFN-\u03b2 on the induction of MHC class II expression and cytokine production by IFN-\u03b3 in THP-1 human monocytic cells","volume":"20","author":"Li","year":"1998","journal-title":"Immunotoxicology"},{"key":"10.1016\/j.bbrep.2020.100866_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-019-03419-4","article-title":"The role of lymphocytes and phagocytes in age-related macular degeneration (AMD)","author":"Behnke","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrep.2020.100866_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.brainres.2007.08.055","article-title":"Interferon-\u03b2 is neuroprotective against the toxicity induced by activated microglia","volume":"1179","author":"Jin","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrep.2020.100866_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jlb.52.2.165","article-title":"Type I interferons (IFN-\u03b1 and -\u03b2) suppress cytotoxin (tumor necrosis factor-\u03b1 and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cells","volume":"52","author":"Abu-khabar","year":"1992","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrep.2020.100866_bib34","doi-asserted-by":"crossref","first-page":"107797","DOI":"10.1016\/j.exer.2019.107797","article-title":"Nanoceria neuroprotective effects in the light-damaged retina: a focus on retinal function and microglia activation","volume":"188","author":"Tisi","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrep.2020.100866_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140387","article-title":"Cerium oxide nanoparticles reduce microglial activation and neurodegenerative events in light damaged retina","volume":"10","author":"Fiorani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2020.100866_bib36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00044011-200323090-00001","article-title":"Dose and frequency of administration of interferon-\u03b2 affect its efficacy in multiple sclerosis","volume":"23","author":"Sharief","year":"2003","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.bbrep.2020.100866_bib37","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.celrep.2019.10.084","article-title":"Cell-type-specific complement expression in the healthy and diseased retina","volume":"29","author":"Pauly","year":"2019","journal-title":"Cell Rep."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240558082030176X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240558082030176X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:44:25Z","timestamp":1778881465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240558082030176X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":37,"alternative-id":["S240558082030176X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2020.100866","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFN-\u03b2 signaling dampens microglia reactivity but does not prevent from light-induced retinal degeneration","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2020.100866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100866"}}